NCT07518472 Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease
| NCT ID | NCT07518472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Pulmonary Disease, Chronic Obstructive (COPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-02-28 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2026-02-28 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic Obstructive Pulmonary Disease is progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity. Pulmonary rehabilitation along with different technqiues of breathing exercises reduces dyspnea and enhance functional capacity by improving ventilatory efficiency, respiratory muscle control and overall exercise tolerance in patients with COPD.
Eligibility Criteria
Inclusion Criteria: * Age between 40-65 years * Both genders (male and female) * Grade 1-3 on mMRC scale of dyspnea * COPD mild stage according to global initiative for chronic obstructive lung -disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted Exclusion Criteria: * Patients having acute exerbation of COPD * Patients diagnosed with acute infection (pmeumonia, T.B) * Any orthopedic or neuromuscular condition that hinders participation in exercise training program * Patients unable to follow command and instructions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07518472 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 65 Years, studying Pulmonary Disease, Chronic Obstructive (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07518472 currently recruiting?
Yes, NCT07518472 is actively recruiting participants. Contact the research team at fanilatamdeen69@gmail.com for enrollment information.
Where is the NCT07518472 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07518472 clinical trial?
NCT07518472 is sponsored by Foundation University Islamabad. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.